|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.703
|
Human |
|
|
external encapsulating structure organization
|
GO:0045229 |
1 |
0.649
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
15 |
0.616
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.581
|
Human |
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.558
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.507
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.503
|
Human |
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.496
|
Human |
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.465
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.406
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.398
|
Human |
|
|
hemoglobin metabolic process
|
GO:0020027 |
3 |
0.389
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.324
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.281
|
|
|
|
erythrocyte development
|
GO:0048821 |
3 |
0.264
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.244
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.242
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.227
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.222
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.221
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.216
|
|
|
|
cell envelope organization
|
GO:0043163 |
1 |
0.208
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.197
|
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
31 |
0.193
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.188
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.183
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.180
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.178
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.177
|
Human |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.175
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.175
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.165
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.160
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.146
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.136
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.136
|
Human |
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.135
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.134
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.133
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.130
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.129
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.121
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.118
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.117
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.116
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.111
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.110
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.107
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.104
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.103
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.102
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.102
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.102
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.101
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.100
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.099
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.099
|
|
|
|
one carbon compound transport
|
GO:0019755 |
4 |
0.098
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.098
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.098
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.098
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.096
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.095
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.094
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.092
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.092
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.090
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.090
|
Human Mouse |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.090
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.089
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
59 |
0.085
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.084
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.083
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.083
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.082
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.079
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.077
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.077
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.076
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.076
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.076
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.073
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.072
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.068
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.067
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.066
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.065
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.065
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.065
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.065
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.064
|
|
|
|
angiotensin activated signaling pathway
|
GO:0038166 |
4 |
0.064
|
|
|
|
memory
|
GO:0007613 |
3 |
0.063
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.062
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
10 |
0.062
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.062
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.062
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
31 |
0.062
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.061
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.060
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.060
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.060
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.060
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.060
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.059
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.059
|
|
|
|
gas transport
|
GO:0015669 |
3 |
0.059
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.058
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.058
|
Human |
|
|
cation transport
|
GO:0006812 |
331 |
0.058
|
Human |
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.057
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.057
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
11 |
0.055
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.054
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.054
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.054
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.053
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.053
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.052
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.052
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.052
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.051
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.050
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.050
|
|
|
|
hemoglobin biosynthetic process
|
GO:0042541 |
3 |
0.050
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.050
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.050
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.049
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.049
|
|
|
|
system process
|
GO:0003008 |
349 |
0.049
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.048
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.048
|
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.048
|
Human |
|
|
response to cytokine
|
GO:0034097 |
232 |
0.048
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.047
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
1 |
0.047
|
|
|
|
negative regulation of astrocyte differentiation
|
GO:0048712 |
1 |
0.047
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.047
|
|
|
|
tetrapyrrole biosynthetic process
|
GO:0033014 |
7 |
0.046
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.046
|
|
|
|
hydrogen peroxide metabolic process
|
GO:0042743 |
20 |
0.046
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.045
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
3 |
0.045
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.045
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.045
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.045
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.045
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.045
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.045
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.044
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.044
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.044
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.044
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.043
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.043
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.043
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.042
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.042
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.042
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.042
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.042
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.042
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.042
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.042
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.042
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.041
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.040
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.040
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.040
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.040
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.040
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.040
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.040
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.039
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.039
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.039
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.039
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.039
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.039
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.038
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
47 |
0.038
|
Mouse |
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.038
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.038
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.038
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.038
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.037
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.037
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.037
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.037
|
|
|
|
porphyrin containing compound biosynthetic process
|
GO:0006779 |
7 |
0.037
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.037
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.036
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.036
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.036
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.036
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.036
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.036
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.036
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.035
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.035
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.035
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.035
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.035
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.035
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.035
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.034
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.034
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.034
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.034
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.034
|
|
|
|
maintenance of protein location in plasma membrane
|
GO:0072660 |
1 |
0.033
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.033
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.033
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.033
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.033
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.033
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.033
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.033
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.032
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.032
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.032
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.032
|
|
|
|
activation of mapk activity
|
GO:0000187 |
45 |
0.032
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.032
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.032
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.032
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.032
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.032
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.032
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.032
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
45 |
0.031
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.031
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.031
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.031
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.031
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.031
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.030
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.030
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.030
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.030
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.030
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.030
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.030
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.029
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.029
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.029
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.029
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.029
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.029
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.028
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.028
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.028
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.028
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.028
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.028
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.028
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.028
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
76 |
0.028
|
Human Mouse |
|
|
vasculature development
|
GO:0001944 |
181 |
0.028
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.028
|
|
|
|
transepithelial ammonium transport
|
GO:0070634 |
3 |
0.028
|
|
|
|
myeloid cell development
|
GO:0061515 |
5 |
0.027
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.027
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.027
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.027
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.027
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.027
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.027
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.027
|
Human |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.027
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.027
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.026
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.026
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.026
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.026
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.026
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.026
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.026
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.026
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.026
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
3 |
0.025
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.025
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.025
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.025
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.025
|
|
|
|
multicellular organismal iron ion homeostasis
|
GO:0060586 |
1 |
0.025
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.025
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.025
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.025
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.025
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.024
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.024
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.024
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.024
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.024
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.024
|
|
|
|
mating
|
GO:0007618 |
1 |
0.024
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.024
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.024
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.024
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.024
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.024
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.024
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.024
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.024
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.024
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.023
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.023
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.023
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.023
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.023
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.023
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.023
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.022
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.022
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.022
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.022
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.022
|
|
|
|
visual learning
|
GO:0008542 |
1 |
0.022
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.022
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.022
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.022
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.022
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.022
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
21 |
0.022
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.022
|
|
|
|
positive regulation of phosphatidylinositol biosynthetic process
|
GO:0010513 |
3 |
0.022
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.022
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.022
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.022
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.022
|
|
|
|
striated muscle cell apoptotic process
|
GO:0010658 |
3 |
0.022
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.022
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.021
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.021
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.021
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.021
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
2 |
0.021
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.021
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.021
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.021
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.021
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.021
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.021
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
49 |
0.020
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.020
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.020
|
|
|
|
response to ph
|
GO:0009268 |
12 |
0.020
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.020
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.020
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.020
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.020
|
|
|
|
cell aggregation
|
GO:0098743 |
1 |
0.020
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.020
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.020
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.020
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.020
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.020
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.020
|
|
|
|
endosome localization
|
GO:0032439 |
2 |
0.020
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.020
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.020
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.020
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.020
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.020
|
|
|
|
interleukin 2 mediated signaling pathway
|
GO:0038110 |
3 |
0.019
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.019
|
|
|
|
regulation of cell proliferation involved in kidney development
|
GO:1901722 |
3 |
0.019
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.019
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.019
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.019
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
1 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.019
|
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.019
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
35 |
0.019
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.018
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.018
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.018
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.018
|
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.018
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.018
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.018
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
42 |
0.018
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.018
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
13 |
0.018
|
|
|
|
adenylate cyclase inhibiting adrenergic receptor signaling pathway
|
GO:0071881 |
1 |
0.018
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.018
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.018
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.018
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.018
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.018
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.018
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.018
|
|
|
|
negative regulation of synaptic transmission
|
GO:0050805 |
2 |
0.018
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.018
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.018
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
38 |
0.018
|
|
|
|
spleen development
|
GO:0048536 |
1 |
0.017
|
|
|
|
carbon dioxide transport
|
GO:0015670 |
3 |
0.017
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.017
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
2 |
0.017
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.017
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.017
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.017
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.017
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.017
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.017
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.017
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.017
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
41 |
0.017
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.017
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.017
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.017
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.017
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.017
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.017
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
49 |
0.017
|
|
|
|
carbohydrate transport
|
GO:0008643 |
37 |
0.017
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.017
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.017
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.016
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.016
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.016
|
|
|
|
activation of mapk activity by adrenergic receptor signaling pathway
|
GO:0071883 |
3 |
0.016
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.016
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.016
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.016
|
|
|
|
positive regulation of cardiac muscle cell apoptotic process
|
GO:0010666 |
1 |
0.016
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.016
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.016
|
|
|
|
urate transport
|
GO:0015747 |
3 |
0.016
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.016
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.016
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.016
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.016
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
8 |
0.016
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.016
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.016
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.016
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.016
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.016
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
41 |
0.016
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.016
|
|
|
|
aging
|
GO:0007568 |
66 |
0.016
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.016
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.016
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.016
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.016
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
33 |
0.016
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.016
|
|